In the news

We welcome public interest in our work.
Get updated on what others are saying about us.

Development of a Novel Osmotic-Pressure-based implantable glucose sensor technology for long-term use in patients with diabetes | Best Practise

Lifecare goes public to support implantable glucose meter | Articles

Scientific posters | Lifecare

Bergensbasert gründerbedrift går på børs: Utvikler avansert diabetes-teknologi

Lifecare goes public to supportimplantable glucose meter

Heading

Publications

Get updated on what we are working on.

Engages Top International Nanotechnology Expert to serve as Scientific Advisor for the Sencell Development

Signs Joint Venture to finalize technical development and explore further opportunities

Insiders buy shares

Lifecare tests groundbreaking technology to analyze human data and strengthens core team

Breakthrough in the attempt to miniaturize the Sencell Glucose Sensor

Share Option Program

Share consolidation and shares to Chairman of Board

Every day we are one step closer to a simpler life for people with diabetes.
Keep track of the development.

Bergensbasert gründerbedrift går på børs: Utvikler avansert diabetes-teknologi

Les mer

Lifecare goes public to supportimplantable glucose meter

Les mer

Heading

Les mer

Bergensbasert gründerbedrift går på børs: Utvikler avansert diabetes-teknologi

Lifecare goes public to supportimplantable glucose meter

Heading